Literature DB >> 15226160

Clinical manifestations and early diagnosis of Sjögren syndrome.

Stuart S Kassan1, Haralampos M Moutsopoulos.   

Abstract

Sjögren syndrome (SS) is a common autoimmune disease evidenced by broad organ-specific and systemic manifestations, the most prevalent being diminished lacrimal and salivary gland function, xerostomia, keratoconjunctivitis sicca, and parotid gland enlargement. Primary SS presents alone, and secondary SS occurs in connection with autoimmune rheumatic diseases. In addition, symptoms do not always present concurrently. This diversity of symptomatic expression adds to the difficulty in initial diagnosis. Armed with the recently refined criteria for diagnosis, specialists, such as rheumatologists, primary care physicians, ophthalmologists, and dentists, who would otherwise focus only on those symptoms that encompass their areas of expertise, can get a comprehensive image of the presenting patient, leading to earlier identification and treatment of SS.

Entities:  

Mesh:

Year:  2004        PMID: 15226160     DOI: 10.1001/archinte.164.12.1275

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  153 in total

1.  Pharmacological cholinergic blockade stimulates inflammatory cytokine production and lymphocytic infiltration in the mouse lacrimal gland.

Authors:  John D Pitcher; Cintia S De Paiva; Flavia S A Pelegrino; Andrew J McClellan; Jagdeep K Raince; Solherny B Pangelinan; Ehsan Rahimy; William J Farley; Michael E Stern; De-Quan Li; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-16       Impact factor: 4.799

2.  Massive cutaneous follicular lymphoid hyperplasia in a patient with the Sjögren syndrome: 7-year follow-up and immunohistochemical study.

Authors:  Yasuhiro Horiuchi; Junichi Hakugawa; Kazuhiro Shimizu; Ichiro Katayama; Tomayoshi Hayashi; Masahiro Kikuchi
Journal:  Rheumatol Int       Date:  2006-04-20       Impact factor: 2.631

Review 3.  Topical and systemic medications for the treatment of primary Sjögren's syndrome.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Antoni Sisó-Almirall; Xavier Bosch; Athanasios G Tzioufas
Journal:  Nat Rev Rheumatol       Date:  2012-05-01       Impact factor: 20.543

Review 4.  Rate, risk factors and causes of mortality in patients with Sjögren's syndrome: a systematic review and meta-analysis of cohort studies.

Authors:  Abha G Singh; Siddharth Singh; Eric L Matteson
Journal:  Rheumatology (Oxford)       Date:  2015-09-27       Impact factor: 7.580

5.  Swallowing Disorders in Sjögren's Syndrome: Prevalence, Risk Factors, and Effects on Quality of Life.

Authors:  Jenny L Pierce; Kristine Tanner; Ray M Merrill; Karla L Miller; Katherine A Kendall; Nelson Roy
Journal:  Dysphagia       Date:  2015-10-19       Impact factor: 3.438

Review 6.  Lessons from diseases mimicking Sjögren's syndrome.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Josep Font
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

Review 7.  [Critical overview of outcome parameters for patients with primary Sjögren's syndrome].

Authors:  E Feist; A Hansen
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

Review 8.  [Epidemiology of primary Sjörgren's syndrome].

Authors:  G Westhoff; A Zink
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

Review 9.  [Pathogenesis and diagnosis of Sjögren's syndrome].

Authors:  T Witte
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

Review 10.  Celiac Disease-Musculoskeletal Manifestations and Mechanisms in Children to Adults.

Authors:  Haley M Zylberberg; Benjamin Lebwohl; Peter H R Green
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.